Skip NavigationSkip to Content

Genetic and Epigenetic Regulation of the Smoothened Gene (SMO) in Cancer Cells

  1. Author:
    Lou,Hong
    Li,Hongchuan [ORCID]
    Huehn, Andrew R [ORCID]
    Tarasova,Nadya
    Saleh, Bahara
    Anderson, Stephen K [ORCID]
    Dean,Michael [ORCID]
  2. Author Address

    Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., National Laboratory for Cancer Research, Gaithersburg, MD 20892, USA., Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510, USA., Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD 20892, USA.,
    1. Year: 2020
    2. Date: Aug 08
    3. Epub Date: 2020 08 08
  1. Journal: Cancers
    1. 12
    2. 8
    3. Pages: pii: E2219
  2. Type of Article: Article
  3. Article Number: 2219
  4. ISSN: 2072-6694
  1. Abstract:

    (1) Background: The hedgehog (HH) signaling pathway is a key regulator of embryonic patterning, tissue regeneration, stem cell renewal, and cancer growth. The smoothened (SMO) protein regulates the HH signaling pathway and has demonstrated oncogenic activity. (2) Methods: To clarify the role of the HH signaling pathway in tumorigenesis, the expression profile of key HH signaling molecules, including SMO, PTCH1, GLI1, GLI2, and GLI3, were determined in 33 cancer cell lines and normal prostate cells and tissues. We performed a computational analysis of the upstream region of the SMO gene to identify the regulatory elements. (3) Results: Three potential CpG islands and several putative SMO promoter elements were identified. Luciferase reporter assays mapped key SMO promoter elements, and functional binding sites for SP1, AP1, CREB, and AP-2a transcription factors in the core SMO promoter region were confirmed. A hypermethylated SMO promoter was identified in several cancer cell lines suggesting an important role for epigenetic silencing of SMO expression in certain cancer cells. (4) Discussion: These results have important implications for our understanding of regulatory mechanisms controlling HH pathway activity and the molecular basis of SMO gene function. Moreover, this study may prove valuable for future research aimed at producing therapeutic downregulation of SMO expression in cancer cells.

    See More

External Sources

  1. DOI: 10.3390/cancers12082219
  2. PMID: 32784501
  3. WOS: 000579605100001
  4. PII : cancers12082219

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel